Form4insider filings, from the source

Insider · CIK 0001459154

Mats Wahlstrom

Files at: CHRS. On EDGAR ↗

1M3M6M1Y2YAll datashares as filed — not split-adjusted
Open-market buys & salesbuys $0 · 0sales $6.0M · 4net −$6.0M
$10k$10k$100k$100k$1M$1M$10M$10MbuyssalesAug 2015Nov 2015Jan 2016Apr 2016Jun 2016Sep 2016Dec 2016

Reported trades — common stock

TradeReported (ET)CompanySharesAvg priceTotalOwned afterΔ stakeFlags
Jun 5, 2026 AForm 4 →Jun 9, 6:40 pm EDTCoherus Oncology, Inc.CHRS30,000——30,000—
Feb 22, 2017 JForm 4 →May 19, 4:05 pm EDTCoherus BioSciences, Inc.CHRS619,914——219,914— plan? late
Dec 7, 2016 SForm 4 →Dec 9, 4:05 pm ESTCoherus BioSciences, Inc.CHRS53,583$27.52$1,474,6770−100% plan?
Aug 18, 2015 SForm 4/A →May 26, 2016, 4:05 pm EDTCoherus BioSciences, Inc.CHRS6,372$33.50$213,475578,528−1.09% plan?
Aug 18, 2015 SForm 4 →Aug 20, 4:05 pm EDTCoherus BioSciences, Inc.CHRS6,373$33.50$213,508578,527−1.09% plan? amended
Aug 17, 2015 SForm 4 →Aug 19, 4:06 pm EDTCoherus BioSciences, Inc.CHRS8,028$33.91$272,225584,900−1.35% plan?
Aug 14, 2015 SForm 4 →Aug 18, 4:05 pm EDTCoherus BioSciences, Inc.CHRS116,554$34.24$3,990,378592,928−16.4% plan?

Reported trades — derivatives (options, RSUs, warrants)

TradeReported (ET)CompanySharesAvg priceTotalOwned afterΔ stakeFlags
Jun 5, 2026 AForm 4 →Jun 9, 6:40 pm EDTCoherus Oncology, Inc.CHRS60,000——60,000—
Jan 11, 2019 AForm 4 →Jan 30, 4:06 pm ESTCoherus BioSciences, Inc.CHRS20,000——20,000— late
Feb 1, 2018 AForm 4 →Feb 5, 4:05 pm ESTCoherus BioSciences, Inc.CHRS20,000——20,000—
May 17, 2017 AForm 4 →May 19, 4:05 pm EDTCoherus BioSciences, Inc.CHRS20,000——20,000—
May 24, 2016 AForm 4 →May 26, 4:07 pm EDTCoherus BioSciences, Inc.CHRS10,000——10,000—
Feb 29, 2016 PForm 4/A →May 26, 4:06 pm EDTCoherus BioSciences, Inc.CHRS1,000,000$22.35$22,350,0001,000,000—
Feb 29, 2016 PForm 4 →Mar 11, 4:05 pm ESTCoherus BioSciences, Inc.CHRS————— late amended
Apr 1, 2015 AForm 4/A →May 27, 4:06 pm EDTCoherus BioSciences, Inc.CHRS95,000——75,000—
Apr 1, 2015 AForm 4 →Apr 3, 4:22 pm EDTCoherus BioSciences, Inc.CHRS95,000——75,000— amended